Literature DB >> 12539554

The experimental study on the effect calcitonin gene-related peptide on bone resorption mediated by interleukin-1.

K Lian1, J Du, Z Rao, H Luo.   

Abstract

To investigate the effect of calcitonin gene-related peptide (CGRP) on bone resorption mediated by interleukin-1 beta(IL-1 beta) in vitro, the osteoclasts isolated from the long bones of newborn SD rats were co-cultured with osteoblasts on ivory slices placed in 24-well plates. 24 h later, conditioned media containing CGRP and/or IL-1 beta were added to the wells respectively, and continued culturing for 48 h. After the cells were stripped off by ultrasonication, the ivory slices were stained in toludine blue. The number and the total area of resorption lacunae on each slice were measured by computer imaging analysis system. Our results showed that IL-1 beta significantly stimulated bone resorption, but CGRP inhibited the effect mediated by IL-1 beta in a dose-dependent manner. It is suggested that CGRP may inhibit osteoclastic bone resorption through two ways: One is that CGRP functions directly on osteoclasts to block their activation; the other is that CGRP regulates the release of cytokines by osteoblasts and indirectly affects the function of osteoclasts.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12539554     DOI: 10.1007/BF02886563

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  9 in total

1.  Osteoclastic bone resorption: in vitro analysis of the rate of resorption and migration of individual osteoclasts.

Authors:  J Kanehisa; J N Heersche
Journal:  Bone       Date:  1988       Impact factor: 4.398

Review 2.  Cytokines and estrogen in bone: anti-osteoporotic effects.

Authors:  M C Horowitz
Journal:  Science       Date:  1993-04-30       Impact factor: 47.728

3.  Interaction of calcitonin and calcitonin gene-related peptide at receptor sites in target tissues.

Authors:  D Goltzman; J Mitchell
Journal:  Science       Date:  1985-03-15       Impact factor: 47.728

4.  The neuropeptide calcitonin gene-related peptide inhibits TNF-alpha but poorly induces IL-6 production by fetal rat osteoblasts.

Authors:  I Millet; A Vignery
Journal:  Cytokine       Date:  1997-12       Impact factor: 3.861

5.  Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats.

Authors:  R B Kimble; J L Vannice; D C Bloedow; R C Thompson; W Hopfer; V T Kung; C Brownfield; R Pacifici
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

6.  Effects of interleukin-1 beta and tumor necrosis factor-alpha on osteoblastic expression of osteocalcin and mineralized extracellular matrix in vitro.

Authors:  R S Taichman; P V Hauschka
Journal:  Inflammation       Date:  1992-12       Impact factor: 4.092

Review 7.  Modulation of osteoclast differentiation by local factors.

Authors:  T Suda; N Udagawa; I Nakamura; C Miyaura; N Takahashi
Journal:  Bone       Date:  1995-08       Impact factor: 4.398

8.  Peripheral monocyte culture supernatants of menopausal women can induce bone resorption: involvement of cytokines.

Authors:  M E Cohen-Solal; A M Graulet; M A Denne; J Gueris; D Baylink; M C de Vernejoul
Journal:  J Clin Endocrinol Metab       Date:  1993-12       Impact factor: 5.958

9.  Osteoblasts mediate interleukin 1 stimulation of bone resorption by rat osteoclasts.

Authors:  B M Thomson; J Saklatvala; T J Chambers
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

  9 in total
  2 in total

Review 1.  Peripheral Nerve Fibers and Their Neurotransmitters in Osteoarthritis Pathology.

Authors:  Susanne Grässel; Dominique Muschter
Journal:  Int J Mol Sci       Date:  2017-04-28       Impact factor: 5.923

2.  Innervation is higher above Bone Remodeling Surfaces and in Cortical Pores in Human Bone: Lessons from patients with primary hyperparathyroidism.

Authors:  Manasi Sayilekshmy; Rie Bager Hansen; Jean-Marie Delaissé; Lars Rolighed; Thomas Levin Andersen; Anne-Marie Heegaard
Journal:  Sci Rep       Date:  2019-03-29       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.